首页> 外文期刊>Medical dosimetry: official journal of the American Association of Medical Dosimetrists >Vector-model-supported optimization in volumetric-modulated arc stereotactic radiotherapy planning for brain metastasis
【24h】

Vector-model-supported optimization in volumetric-modulated arc stereotactic radiotherapy planning for brain metastasis

机译:脑转移的体积调制弧立体定向放射治疗计划中的矢量模型支持优化

获取原文
获取原文并翻译 | 示例
           

摘要

Long planning time in volumetric-modulated arc stereotactic radiotherapy (VMA-SRT) cases can limit its clinical efficiency and use. A vector model could retrieve previously successful radiotherapy cases that share various common anatomic features with the current case. The prsent study aimed to develop a vector model that could reduce planning time by applying the optimization parameters from those retrieved reference cases. Thirty-six VMA-SRT cases of brain metastasis (gender, male [n = 23], female [n = 13]; age range, 32 to 81 years old) were collected and used as a reference database. Another 10 VMA-SRT cases were planned with both conventional optimization and vector-model-supported optimization, following the oncologists' clinical dose prescriptions. Planning time and plan quality measures were compared using the 2-sided paired Wilcoxon signed rank test with a significance level of 0.05, with positive false discovery rate (pFDR) of less than 0.05. With vector-model-supported optimization, there was a significant reduction in the median planning time, a 40% reduction from 3.7 to 22 hours (p = 0.002, pFDR = 0.032), and for the number of iterations, a 30% reduction from 8.5 to 6.0 (p = 0.006, pFDR = 0.047). The quality of plans from both approaches was comparable. From these preliminary results, vector-model-supported optimization can expedite the optimization of VMA-SRT for brain metastasis while maintaining plan quality. (C) 2017 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.
机译:体积调制弧立体定向放射疗法(VMA-SRT)案例的长规划时间可以限制其临床效率和使用。向量模型可以检索以前成功的放射疗法案例,其具有当前情况的各种常见的解剖功能。普遍的研究旨在开发一种矢量模型,该矢量模型可以通过将优化参数应用于从那些检索到的参考案例来降低规划时间。脑转移的36例VMA-SRT病例(性别,雄性[n = 23],女性[n = 13];年龄范围,32至81岁)被收集并用作参考数据库。在肿瘤学家的临床剂量处方之后,计划在常规优化和载体模型支持的优化中计划另外10个VMA-SRT病例。使用双面成对的Wilcoxon符号测试进行比较规划时间和计划质量措施,其显着性水平为0.05,具有阳性假发现率(PFDR)小于0.05。随着载体模型支持的优化,中值规划时间有显着降低,从3.7〜22小时减少40%(P = 0.002,PFDR = 0.032),以及迭代的数量,减少30% 8.5至6.0(p = 0.006,pfdr = 0.047)。两种方法的计划质量是可比的。从这些初步结果来看,向量模型支持的优化可以加快优化VMA-SRT的脑转移,同时保持计划质量。 (c)2017年美国医疗剂量分子协会。由elsevier Inc.保留所有权利发布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号